All AbMole products are for research use only, cannot be used for human consumption.
TG100-115 is a potent small molecule PI3K γ/δ inhibitor potently inhibited edema and inflammation in response to multiple mediators known to participate in myocardial infarction, including vascular endothelial growth factor and platelet-activating factor. TG100-115, inhibited PI3Kγ and -δ (IC50 values of 83 and 235 nM, respectively), whereas both PI3Kα and -β were relatively unaffected (IC50 values >1 μM). TG100-115 also blocked histamine-induced permeability, as predicted based on PI3K's role in GPCR signaling. Additionally, TG100-115 did not block VEGF-induced angiogenesis in vivo.
 |
Source | Cancer Discov (2016). Figure 4.TG100-115 |
| Method | i.v. | |
| Cell Lines | WT mice | |
| Concentrations | 10 mg/kg | |
| Incubation Time | 48 hours | |
| Results | Intravital imaging revealed that control-treated mice exhibited large pancreatic tumors and multiple metastases, whereas TG100-115–treated mice had signifi cantly smaller pancreatic tumors and few, if any, metastases |
| Cell Experiment | |
|---|---|
| Cell lines | Human umbilical vein EC |
| Preparation method | Cell proliferation assay. Human umbilical vein EC plated in 96-well cluster plates (5,000 cells/well) were cultured in assay medium (containing 0.5% serum and 50 ng/ml VEGF) in the presence or absence of test compounds (10 μM), and cell numbers were quantified by XTT assay (Promega, Madison, WI) 24, 48, or 72 h later. |
| Concentrations | 10 μM |
| Incubation time | 24, 48, or 72 h |
| Animal Experiment | |
|---|---|
| Animal models | Rodent and porcine MI models |
| Formulation | either PEG or sulfobutyl ether β-cyclodextrin (CyDex, Lenexa, KS) formulations |
| Dosages | 0.5mg/kg or 1mg/kg |
| Administration | i.v. at 0–3 h after reperfusion |
| Molecular Weight | 346.34 |
| Formula | C18H14N6O2 |
| CAS Number | 677297-51-7 |
| Solubility (25°C) | DMSO 9 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related PI3K Products |
|---|
| AS605240
AS-605240 is a potent and selective inhibitor of PI 3-kinase γ (PI3Kγ) with an IC50 of 8 nM. |
| BEZ235
BEZ235 (NVP-BEZ235) is a potent dual PI3K and mTOR inhibitor of p110α, p110γ, p110δ and p110β with IC50 of 4 nM, 5 nM, 7 nM and 75 nM, respectively. |
| BKM120 (Buparlisib)
BKM120 (NVP-BKM120) is a potent and highly specific oral pan-class I PI3K inhibitor. |
| GDC-0941 (Pictilisib)
GDC-0941 is a selective and potent inhibitor of Class I PI3K, p110a IC50=0.003uM, U87MG IC50=0.95μM. |
| AS-252424
AS-252424 is a furan-2-ylmethylene thiazolidinedione as a selective ATP-competitive PI3Kγ inhibitor with IC50 with 33 nM. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
